Rheumatoid arthritis: Developing new oral targeted therapies for RA can be challenging.
University of Texas Southwestern Medical Center at Dallas, Metroplex Clinical Research Center, 8144 Walnut Hill Lane, Suite 800, Dallas, TX 75231, USA.
Roy M
RM
Fleischmann
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000000981:diagnostic imaging / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic / Q000379:methods; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods; D011859:Radiography
D018501:Antirheumatic Agents